SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
Abstract The aim of this study is to understand adaptive immunity to SARS-CoV-2 through the analysis of B cell epitope and neutralizing activity in coronavirus disease 2019 (COVID-19) patients. We obtained serum from forty-three COVID-19 patients from patients in the intensive care unit of Osaka Uni...
Guardado en:
Autores principales: | Shota Yoshida, Chikako Ono, Hiroki Hayashi, Shinya Fukumoto, Satoshi Shiraishi, Kazunori Tomono, Hisashi Arase, Yoshiharu Matsuura, Hironori Nakagami |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/972cb6e1631a4f828f36760167864d12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
por: Shota Yoshida, et al.
Publicado: (2020) -
Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help
por: Lina Sun, et al.
Publicado: (2020) -
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Guillaume Beaudoin-Bussières, et al.
Publicado: (2020) -
Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey
por: Munehisa Shimamura, et al.
Publicado: (2021) -
The HSP70-fused foot-and-mouth disease epitope elicits cellular and humoral immunity and drives broad-spectrum protective efficacy
por: Hyundong Jo, et al.
Publicado: (2021)